Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sudhir Bansod"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sudhir Bansod, Sushil Pande
Publikováno v:
Indian Journal of Drugs in Dermatology, Vol 1, Iss 1, Pp 4-6 (2015)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::c16fa6a743804971789813d360a190e2
http://www.ijdd.in/article.asp?issn=2455-3972
http://www.ijdd.in/article.asp?issn=2455-3972
Autor:
Tom Chu, Markus Britschgi, Eric Prinssen, Regina Dutkowski, Annette Koerner, Bharat Thakrar, Sudhir Bansod, Craig R Rayner, Stephen Toovey, Alexandra Sirzen-Zelenskaya, Barbara Donner
Publikováno v:
Advances in Therapy. 29:826-848
A 2008 review by our group concluded that the risk of neuropsychiatric adverse events (NPAEs) in influenza patients was not increased by oseltamivir exposure, and did not identify any mechanism by which oseltamivir or its metabolites could cause or w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a800f3402028225d61815a79d7c95de9
https://doi.org/10.1007/s12325-012-0050-8
https://doi.org/10.1007/s12325-012-0050-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Annette Körner, Thomas Weiser, Thomas Singer, Barbara Donner, Alexander Breidenbach, Laurent Gand, Muriel Bellot, Christian Freichel, Eric Prinssen, Sudhir Bansod, Silvia Gatti, Gerhard Hoffmann
Publikováno v:
Basic & Clinical Pharmacology & Toxicology.
Oseltamivir is widely used for the treatment and prophylaxis of influenza. Renewed interest in the central nervous system (CNS) tolerability profile of oseltamivir has been triggered by the reports of neuropsychiatric adverse events in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2e5136c62e5290592c04da255285ad1
https://doi.org/10.1111/j.1742-7843.2012.00861.x
https://doi.org/10.1111/j.1742-7843.2012.00861.x
Autor:
Martin T. Schaerer, Miriam Adamcova, Loredana Regep, Patricia Schlagenhauf, Sudhir Bansod, Hans-Georg Rhein
Publikováno v:
Malaria Journal
Malaria Journal, Vol 10, Iss 1, p 292 (2011)
Malaria Journal, Vol 10, Iss 1, p 292 (2011)
Background Use of anti-malarial medication in children is hampered by a paucity of dosage, pharmacokinetic and tolerability data. Methods Data on the use of mefloquine in children, particularly in young children weighing less than 20 kg, were reviewe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11df45801a453e40939322fbc3e94562
https://doi.org/10.1186/1475-2875-10-292
https://doi.org/10.1186/1475-2875-10-292